UCB Divests Products, Manufacturing Site In China To CBC, Mubadala

Deal Snapshot: The Belgian company follows a tradition of Western pharma companies relying on local expertise to market their products in China.

Shanghai
UCB sells off China rights to several products to CBC, Mubadala • Source: Shutterstock

More from Strategy

More from Business